AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Danguy, A Rorive, S Decaestecker, C Bronckart, Y Kaltner, H Hadari, YR Goren, R Zich, Y Petein, M Salmon, I Gabius, HJ Kiss, R
Citation: A. Danguy et al., Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system, HIST HISTOP, 16(3), 2001, pp. 861-868

Authors: Darro, F Schwarz, G Petein, M Schwarz, S Chaboteaux, C Nogaret, JM Decaestecker, C Salmon, I Kiss, R
Citation: F. Darro et al., Characterization of steroid hormone sensitivity in human breast cancers maintained ex vivo under organotypical culture conditions, J CANC RES, 126(5), 2000, pp. 257-262

Authors: Nortier, JL Martinez, MM Schmeiser, HH Arlt, VM Bieler, CA Petein, M Depierreux, MF De Pauw, L Abramowicz, D Vereerstraeten, P Vanherweghem, JL
Citation: Jl. Nortier et al., Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)., N ENG J MED, 342(23), 2000, pp. 1686-1692

Authors: van Velthoven, R Petein, M Oosterlinck, W De Wilde, T Mattelaer, J Hardeman, M Kiss, R Decaestecker, C
Citation: R. Van Velthoven et al., Identification by quantitative chromatin pattern analysis of patients at risk for recurrence of superficial transitional bladder carcinoma, J UROL, 164(6), 2000, pp. 2134-2137

Authors: Zlotta, AR Djavan, B Damoun, M Roumeguere, T Petein, M Entezari, K Marberger, M Schulman, CC
Citation: Ar. Zlotta et al., The importance of measuring the prostatic transition zone: an anatomical and radiological study, BJU INT, 84(6), 1999, pp. 661-666

Authors: Kanfaoui, A Graide, D Petein, M Kengo, JJ Denis, R
Citation: A. Kanfaoui et al., Proteus mirabilis osteomyelitis of the ribs in a girl with sickle cell anaemia, EUR J PED, 158(9), 1999, pp. 767-767

Authors: Darro, F Cahen, P Vianna, A Decaestecker, C Nogaret, JM Leblond, B Chaboteaux, C Ramos, C Petein, M Budel, V Schoofs, A Pourrias, B Kiss, R
Citation: F. Darro et al., Growth inhibition of human in vitro and mouse in vitro and in vivo mammarytumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen, BREAST CANC, 51(1), 1998, pp. 39-55
Risultati: 1-7 |